These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37187609)

  • 1. Striatal spatial heterogeneity, clustering, and white matter association of GFAP
    Brown TG; Thayer MN; VanTreeck JG; Zarate N; Hart DW; Heilbronner S; Gomez-Pastor R
    Front Cell Neurosci; 2023; 17():1094503. PubMed ID: 37187609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice.
    Vagner T; Dvorzhak A; Wójtowicz AM; Harms C; Grantyn R
    Mol Cell Neurosci; 2016 Dec; 77():76-86. PubMed ID: 27989734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic response of striatal astrocytes to dopamine depletion.
    Zhu YF; Wang WP; Zheng XF; Chen Z; Chen T; Huang ZY; Jia LJ; Lei WL
    Neural Regen Res; 2020 Apr; 15(4):724-730. PubMed ID: 31638097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
    Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
    Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington's disease.
    Kim J; Waldvogel HJ; Faull RL; Curtis MA; Nicholson LF
    J Neurochem; 2015 Sep; 134(5):927-42. PubMed ID: 26011179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice.
    Jiang R; Diaz-Castro B; Looger LL; Khakh BS
    J Neurosci; 2016 Mar; 36(12):3453-70. PubMed ID: 27013675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.
    Saba J; López Couselo F; Turati J; Carniglia L; Durand D; de Laurentiis A; Lasaga M; Caruso C
    J Neuroinflammation; 2020 Oct; 17(1):290. PubMed ID: 33023623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial proliferation and astrocytic protein alterations in the human Huntington's disease cortex.
    Tan AYS; Tippett LJ; Turner CP; Swanson MEV; Park TIH; Curtis MA; Faull RLM; Dragunow M; Singh-Bains MK
    Neurobiol Dis; 2024 Aug; 198():106554. PubMed ID: 38844243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
    Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
    Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B.
    Batassini C; Broetto N; Tortorelli LS; Borsoi M; Zanotto C; Galland F; Souza TM; Leite MC; Gonçalves CA
    Neural Plast; 2015; 2015():387028. PubMed ID: 26090233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.
    Faideau M; Kim J; Cormier K; Gilmore R; Welch M; Auregan G; Dufour N; Guillermier M; Brouillet E; Hantraye P; Déglon N; Ferrante RJ; Bonvento G
    Hum Mol Genet; 2010 Aug; 19(15):3053-67. PubMed ID: 20494921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics.
    Stanek LM; Bu J; Shihabuddin LS
    Neurobiol Dis; 2019 Sep; 129():29-37. PubMed ID: 31042572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2016 Aug; 36(34):8790-801. PubMed ID: 27559163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease.
    You H; Wu T; Du G; Huang Y; Zeng Y; Lin L; Chen D; Wu C; Li X; Burgunder JM; Pei Z
    Front Neurol; 2021; 12():779890. PubMed ID: 34867769
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of spinal cord glial cells in a model of hindlimb unloading in mice.
    Chelyshev YA; Muhamedshina YO; Povysheva TV; Shaymardanova GF; Rizvanov AA; Nigmetzyanova MV; Tiapkina OV; Bondarenko NI; Nikolskiy EE; Islamov RR
    Neuroscience; 2014 Nov; 280():328-39. PubMed ID: 25218808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
    Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
    J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
    Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
    Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Tousley A; Valentine DT; Sapp E; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Oct; 5(3):249-260. PubMed ID: 27689619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.